Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Feasibility and Utility of the Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.
Journal: The Clinical journal of pain
Published: November 09, 2016
Response: Is It Truly the Answer? Personalized Oxycodone Dosing Based on Pharmacogenetic Testing and Corresponding Pharmacokinetics.
Journal: Pain medicine (Malden, Mass.)
Published: November 03, 2015
Methadone Recycling Sustains Drug Reservoir in Tissue.
Journal: Journal of pain & palliative care pharmacotherapy
Published: September 15, 2015
In silico ordinary differential equation/partial differential equation hemodialysis model estimates methadone removal during dialysis.
Journal: Journal of pain research
Published: August 01, 2015
Integrating Clinical Pharmacokinetics, Pharmacogenetics, and Quantitative Cytochrome P450 Polymorphic Gene Drug-Drug Interactions (DDIs).
Journal: Pain physician
Published: May 23, 2015
Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.
Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.
Journal: The Clinical journal of pain
Published: January 27, 2015
CYP2D6 phenotype-specific codeine population pharmacokinetics.
Journal: Journal of pain & palliative care pharmacotherapy
Published: January 07, 2015
A transit compartment model unmasks OxyContin's reflective pharmacokinetics from urine measurements in humans.
Journal: Journal of pain & palliative care pharmacotherapy
Published: May 13, 2014
Oxycodone recycling: a novel hypothesis of opioid tolerance development in humans.
Journal: Medical hypotheses
Published: April 23, 2014
Organ-specific microcirculatory mass transport of oxycodone in humans: clinical implications for therapeutic use.
Journal: The Clinical journal of pain
Published: April 09, 2014
Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.
Journal: Pain medicine (Malden, Mass.)
Published: February 13, 2014
The CYP2D6 gene determines oxycodone's phenotype-specific addictive potential: implications for addiction prevention and treatment.
Journal: Medical hypotheses
Published: September 26, 2013
Last Updated: 09/26/2026